These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12186375)

  • 1. Using cost-effectiveness analysis to define a breast cancer benefits package for the uninsured.
    Malin JL; Keeler E; Wang C; Brook R
    Breast Cancer Res Treat; 2002 Jul; 74(2):143-53. PubMed ID: 12186375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost comparison of mastectomy versus breast-conserving therapy for early-stage breast cancer.
    Barlow WE; Taplin SH; Yoshida CK; Buist DS; Seger D; Brown M
    J Natl Cancer Inst; 2001 Mar; 93(6):447-55. PubMed ID: 11259470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefits and costs of screening and treatment for early breast cancer. Development of a basic benefit package.
    Kattlove H; Liberati A; Keeler E; Brook RH
    JAMA; 1995 Jan; 273(2):142-8. PubMed ID: 7799495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shouldn't cost be considered a significant issue in medical care?
    Holden JL
    Am J Surg; 2002 Jan; 183(1):4-6. PubMed ID: 11869693
    [No Abstract]   [Full Text] [Related]  

  • 5. Economic evaluation of the prevention and treatment of breast cancer--present status and open issues.
    Imai H; Kuroi K; Ohsumi S; Ono M; Shimozuma K
    Breast Cancer; 2007; 14(1):81-7. PubMed ID: 17245000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic evaluation of breast cancer treatment: considering the value of patient choice.
    Polsky D; Mandelblatt JS; Weeks JC; Venditti L; Hwang YT; Glick HA; Hadley J; Schulman KA
    J Clin Oncol; 2003 Mar; 21(6):1139-46. PubMed ID: 12637482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-utility analysis of four common surgical treatment pathways for breast cancer.
    Kouwenberg CAE; Mureau MAM; Kranenburg LW; Rakhorst H; de Leeuw D; Klem TMAL; Koppert LB; Ramos IC; Busschbach JJ
    Eur J Surg Oncol; 2021 Jun; 47(6):1299-1308. PubMed ID: 33349523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness assessment of lumpectomy cavity boost in elderly women with early stage estrogen receptor positive breast cancer receiving adjuvant radiotherapy.
    Lester-Coll NH; Rutter CE; Evans SB
    Radiother Oncol; 2016 Apr; 119(1):52-6. PubMed ID: 26867968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost-effectiveness of adjuvant chemotherapy for early breast cancer: A comparison of no chemotherapy and first, second, and third generation regimens for patients with differing prognoses.
    Campbell HE; Epstein D; Bloomfield D; Griffin S; Manca A; Yarnold J; Bliss J; Johnson L; Earl H; Poole C; Hiller L; Dunn J; Hopwood P; Barrett-Lee P; Ellis P; Cameron D; Harris AL; Gray AM; Sculpher MJ
    Eur J Cancer; 2011 Nov; 47(17):2517-30. PubMed ID: 21741831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using the 21-gene assay to guide adjuvant chemotherapy decision-making in early-stage breast cancer: a cost-effectiveness evaluation in the German setting.
    Blohmer JU; Rezai M; Kümmel S; Kühn T; Warm M; Friedrichs K; Benkow A; Valentine WJ; Eiermann W
    J Med Econ; 2013; 16(1):30-40. PubMed ID: 22966753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness Analysis Comparing Conventional, Hypofractionated, and Intraoperative Radiotherapy for Early-Stage Breast Cancer.
    Deshmukh AA; Shirvani SM; Lal L; Swint JM; Cantor SB; Smith BD; Likhacheva A
    J Natl Cancer Inst; 2017 Nov; 109(11):. PubMed ID: 29059428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost analysis of breast conservation surgery compared with modified radical mastectomy with and without reconstruction.
    Palit TK; Miltenburg DM; Brunicardi FC
    Am J Surg; 2000 Jun; 179(6):441-5. PubMed ID: 11004327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost and Cost-Effectiveness of Image Guided Partial Breast Irradiation in Comparison to Hypofractionated Whole Breast Irradiation.
    Shah C; Ward MC; Tendulkar RD; Cherian S; Vicini F; Singer ME
    Int J Radiat Oncol Biol Phys; 2019 Feb; 103(2):397-402. PubMed ID: 30253236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment variation by insurance status for breast cancer patients.
    Coburn N; Fulton J; Pearlman DN; Law C; DiPaolo B; Cady B
    Breast J; 2008; 14(2):128-34. PubMed ID: 18315690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-Effectiveness Modeling of Surgery Plus Adjuvant Endocrine Therapy Versus Primary Endocrine Therapy Alone in UK Women Aged 70 and Over With Early Breast Cancer.
    Holmes GR; Ward SE; Brennan A; Bradburn M; Morgan JL; Reed MWR; Richards P; Rafia R; Wyld L;
    Value Health; 2021 Jun; 24(6):770-779. PubMed ID: 34119074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generalised cost-effectiveness analysis for breast cancer prevention and care in Hong Kong Chinese.
    Wong IO; Tsang JW; Cowling BJ; Leung GM
    Hong Kong Med J; 2015 Dec; 21 Suppl 6():9-12. PubMed ID: 26645875
    [No Abstract]   [Full Text] [Related]  

  • 17. Decision-analytic model and cost-effectiveness evaluation of postmastectomy radiation therapy in high-risk premenopausal breast cancer patients.
    Lee JH; Glick HA; Hayman JA; Solin LJ
    J Clin Oncol; 2002 Jun; 20(11):2713-25. PubMed ID: 12039934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of different surgical treatment approaches for early breast cancer: a retrospective matched cohort study from China.
    Yang Q; Zhong X; Zhang W; Luo T; He P; Zheng H
    BMC Cancer; 2021 Feb; 21(1):107. PubMed ID: 33530955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The INTRABEAM® Photon Radiotherapy System for the adjuvant treatment of early breast cancer: a systematic review and economic evaluation.
    Picot J; Copley V; Colquitt JL; Kalita N; Hartwell D; Bryant J
    Health Technol Assess; 2015 Aug; 19(69):1-190. PubMed ID: 26323045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic evaluation of genomic test-directed chemotherapy for early-stage lymph node-positive breast cancer.
    Hall PS; McCabe C; Stein RC; Cameron D
    J Natl Cancer Inst; 2012 Jan; 104(1):56-66. PubMed ID: 22138097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.